e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Uncontrolled and severe asthma in children
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A new observer independent method to assess therapy response in children with severe asthma based on daily lung function
N. van Sprang, E. Delgado-Eckert, C. Häcki, A. Bosschaart, U. Frey, A. Boehmer (Rotterdam, Netherlands; Basel, Davos, Switzerland)
Source:
Annual Congress 2013 –Uncontrolled and severe asthma in children
Session:
Uncontrolled and severe asthma in children
Session type:
Thematic Poster Session
Number:
1137
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. van Sprang, E. Delgado-Eckert, C. Häcki, A. Bosschaart, U. Frey, A. Boehmer (Rotterdam, Netherlands; Basel, Davos, Switzerland). A new observer independent method to assess therapy response in children with severe asthma based on daily lung function. Eur Respir J 2013; 42: Suppl. 57, 1137
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Xavier Quantin (Montpellier, France) - 09.09.2013 11:15
Hello, this is a very interresting abstract. How many patients were included and what was the retention rate? X Quantin France Montpellier
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
A pilot study for markers which can reflect asthmatic activity before and after reduction of inhaled corticosteroids
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Is it possible to identify phenotypes of problematic severe asthma in children using fluctuation based clustering?
Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques
Year: 2016
Reproducibility and stability of severe asthma research program (SARP) clinical cluster phenotypes in SARP3
Source: International Congress 2016 – Phenotyping asthma
Year: 2016
Global evaluation of treatment effectiveness (GETE) is an accurate predictor of response to omalizumab in patients with severe allergic asthma: A pooled analysis
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014
Assessing the risk of future severe asthma exacerbations using CARAT questionnaire and lung function
Source: Annual Congress 2013 –Lung function tests to monitor airway diseases
Year: 2013
Comparison of clinical features of severe persistent asthma and refractory asthma
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013
Prediction of asthma control and treatment changes in obstructive asthmatic children
Source: International Congress 2016 – Techniques and tools in paediatric asthma
Year: 2016
Positive bronchodilator response is a poor predictor of future risk in well controlled asthma patients
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016
Based on what parameters of clinical remission should inhaled corticosteroids be stopped in children with asthma?
Source: Annual Congress 2013 –The best of paediatric asthma and allergy
Year: 2013
4–year trajectory of medication adherence amongst severe asthma patients: Risk factors and impact on asthma control
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016
Usefulness of induced sputum eosinophil count to assess severity and treatment outcome in asthma patients
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Quantitative analysis of severe asthma exacerbation requiring continuous inhalation therapy by measurements of modified pulmonary index score
Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Year: 2013
A scoring algorithm for predicting the presence of adult asthma
Source: Annual Congress 2013 –Lung function tests to monitor airway diseases
Year: 2013
QAW039 (fevipiprant) improves lung function and control of asthma symptoms in patients with more severe air flow limitation: A proof-of-concept study
Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Year: 2015
The parameters that may affect inhalation therapy success in elderly COPD and asthma patients
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015
Clinical-functional and inflammatory evolution after one year of tracking in patients with asthma according to induced sputum cellularity
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015
Developing integrated mental health and asthma treatment protocol using quality improvement methods
Source: International Congress 2016 – Asthma points to ponder
Year: 2016
T
H
2 specific biomarker profile determines steroid responsiveness in severe asthma
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013
Prevalence of refractory asthma in population with severe asthma
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
ADEPT, airway disease endotyping for personalized treatment: Interim analysis of asthma patients
Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept